Zobrazeno 1 - 10
of 125
pro vyhledávání: '"resistant cell lines"'
Publikováno v:
Open Medicine, Vol 18, Iss 1, Pp 313-109 (2023)
Acquired resistance to chemotherapeutic drugs in gallbladder cancer (GBC) results in therapy failure. This study is aimed to establish oxaliplatin (OXA)-resistant GBC cell lines and uncover their gene expression profiles. First, two OXA-resistant GBC
Externí odkaz:
https://doaj.org/article/a8299bf6c86f4047b7a39d624fc40983
Autor:
Jiarong Zhou, Linshi Zhang, Huilin Zheng, Wenhao Ge, Yu Huang, Yingcai Yan, Xiaohu Zhou, Wei Zhu, Yang Kong, Yuan Ding, Weilin Wang
Publikováno v:
Cancer Medicine, Vol 9, Iss 3, Pp 1115-1130 (2020)
Abstract Gemcitabine (GEM) alone and GEM‐based chemotherapy are the preferred regimens for treating advanced unresectable and metastatic pancreatic cancer (PC). However, these treatments have limited efficacy due to acquired resistance of cancer ce
Externí odkaz:
https://doaj.org/article/df25b615a550416794146ecdaeb94d30
Publikováno v:
AGRIVITA Journal of Agricultural Science, Vol 40, Iss 3, Pp 434-441 (2018)
The research aimed to develop a rice cell culture system with high proliferation and screening resistant cell lines of rice to bacterial blight disease caused by Xanthomonas oryza pv. oryzae (Xoo). The culture cells obtained from the callus, cultured
Externí odkaz:
https://doaj.org/article/b721108de13c466c98200fdfc9478345
Autor:
István Szász, Viktória Koroknai, Vikas Patel, Tibor Hajdú, Tímea Kiss, Róza Ádány, Margit Balázs
Publikováno v:
Biomedicines, Vol 9, Iss 2, p 96 (2021)
HA15 is a new anti-melanoma drug that triggers endoplasmic reticulum (ER) stress and causes deleterious effects on melanoma cell viability due to autophagy and apoptosis, regardless of driver mutations or drug resistance. In this study, we investigat
Externí odkaz:
https://doaj.org/article/b9fbfd75fec64e98b018658eb0becfe8
Autor:
Chung Lyul Lee, Minji Lee, Ji Yong Lee, Sin-hyoung Hong, Seung Woo Yang, Ji-hyeon Min, Dong-eon Lee, Joonyoung Baek, Chanseul Kim, Jae Sung Lim, Ki Hak Song, Ju Hyun Shin, Gun-Hwa Kim
Publikováno v:
Cancers; Volume 14; Issue 16; Pages: 3959
Castration-resistant prostate cancer (CRPC) is still a major concern in men’s health, with 375,000 cancer deaths annually. Hypoxia, which is a marked characteristic of advanced solid tumors, has been suggested to induce prostate cancer towards CRPC
Autor:
Anita Thomas, Kimberly Sue Slade, Roman A. Blaheta, Sascha D. Markowitsch, Philipp Stenzel, Katrin E. Tagscherer, Wilfried Roth, Mario Schindeldecker, Martin Michaelis, Florian Rothweiler, Jaroslav Cinatl, Robert Dotzauer, Olesya Vakhrusheva, Maarten Albersen, Axel Haferkamp, Eva Juengel, Jindrich Cinatl, Igor Tsaur
Publikováno v:
Cancers; Volume 14; Issue 7; Pages: 1683
Whereas the lack of biomarkers in penile cancer (PeCa) impedes the development of efficacious treatment protocols, preliminary evidence suggests that c-MET and associated signaling elements may be dysregulated in this disorder. In the following study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2960efb4e5907a67d482a14600addf45
https://kar.kent.ac.uk/95208/1/cancers-14-01683-v2.pdf
https://kar.kent.ac.uk/95208/1/cancers-14-01683-v2.pdf
Autor:
Xiaohu Zhou, Yang Kong, Yingcai Yan, Wenhao Ge, Yu Huang, Wei Zhu, Weilin Wang, Linshi Zhang, Jiarong Zhou, Yuan Ding, Huilin Zheng
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 3, Pp 1115-1130 (2020)
Cancer Medicine, Vol 9, Iss 3, Pp 1115-1130 (2020)
Gemcitabine (GEM) alone and GEM‐based chemotherapy are the preferred regimens for treating advanced unresectable and metastatic pancreatic cancer (PC). However, these treatments have limited efficacy due to acquired resistance of cancer cells to ch
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Igor Tsaur, Anita Thomas, Michelle Monecke, Marion Zugelder, Jochen Rutz, Timothy Grein, Sebastian Maxeiner, Hui Xie, Felix K.-H. Chun, Florian Rothweiler, Jindrich Cinatl, Martin Michaelis, Axel Haferkamp, Roman A. Blaheta
Publikováno v:
Cancers
Cancers; Volume 14; Issue 13; Pages: 3111
Cancers; Volume 14; Issue 13; Pages: 3111
Despite recent advances in the treatment of metastatic prostate cancer (PCa), resistance development after taxane treatments is inevitable, necessitating effective options to combat drug resistance. Previous studies indicated antitumoral properties o